U. Delaware Reaches Accord On Race Studies

Professors hotly debated it, students protested it, and volumes of legal documents were drafted concerning it. But after nearly 2 1/2 years of turmoil, controversial race research at the University of Delaware will be allowed to continue. On April 29, the university's administration quietly reached a settlement of a labor grievance with two educational studies professors, allowing them to accept previously blocked funds for conducting research into the relationship between race and intelligen

Written byRon Kaufman
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

On April 29, the university's administration quietly reached a settlement of a labor grievance with two educational studies professors, allowing them to accept previously blocked funds for conducting research into the relationship between race and intelligence.

"This whole ordeal has hurt them, hurt us, and hurt the institution. I hope that, with this settlement, we will put this behind us," says Linda Gottfredson, who, along with Jan Blits, will continue to receive money from the Pioneer Fund--a New York funding agency that many at the Newark campus believe was founded on a racist ideology.

The 45-year-old fund, whose charter proclaims its support of eugenics, has been accused of financing racist research and assisting anti-immigration lobbies (see story on page 6).

"Thank God for the Pioneer Fund," says J. Philippe Rushton, a developmental personality psychologist at the University of Western Ontario. "There are precious few financial resources available for race research. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies